Thomas Cerny
Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood
Reinhart W, Baerlocher G, Cerny T, Owen G, Meiselman H, Beer J. Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood. European journal of haematology 1999; 62:223-30.
01.04.1999Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood
01.04.1999European journal of haematology 1999; 62:223-30
Reinhart W H, Baerlocher G M, Cerny Thomas, Owen G R, Meiselman H J, Beer J H
T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease
Bättig B, Mueller-Garamvoelgyi E, Cogliatti S, Schmid U, Kappeler A, Cerny T, Laissue J, Fey M. T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease. Leukemia & lymphoma 1999; 33:393-8.
01.04.1999T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease
01.04.1999Leukemia & lymphoma 1999; 33:393-8
Bättig B, Mueller-Garamvoelgyi E, Cogliatti S B, Schmid U, Kappeler A, Cerny Thomas, Laissue J A, Fey M F
[Quality of life of patients with metastatic breast or intestinal cancer, treated with anthroposophic medicine or with mainstream medicine, the latter with or without psycho-oncologic or supplementary anthroposophic therapy]
Cerny T, Heusser P. [Quality of life of patients with metastatic breast or intestinal cancer, treated with anthroposophic medicine or with mainstream medicine, the latter with or without psycho-oncologic or supplementary anthroposophic therapy]. Forschende Komplementärmedizin 1999; 6 Suppl 1:35-7.
01.02.1999[Quality of life of patients with metastatic breast or intestinal cancer, treated with anthroposophic medicine or with mainstream medicine, the latter with or without psycho-oncologic or supplementary anthroposophic therapy]
01.02.1999Forschende Komplementärmedizin 1999; 6 Suppl 1:35-7
Cerny Thomas, Heusser P
Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial
Stupp R, Giroux B, Schläpfer J, Sarkany M, Bastian G, Sessa C, Cerny T, Gerard B, Pagani O, Bauer J, Leyvraz S. Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998; 9:1233-42.
01.11.1998Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial
01.11.1998Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998; 9:1233-42
Stupp R, Giroux B, Schläpfer J, Sarkany M, Bastian G, Sessa C, Cerny Thomas, Gerard B, Pagani O, Bauer J, Leyvraz S
The cognitive-spiritual dimension--an important addition to the assessment of quality of life: validation of a questionnaire (SELT-M) in patients with advanced cancer
Van Wegberg B, Castiglione M, Hürny C, Bernhard J, Von Rohr E, Schaad R, Helwig S, Heusser P, Bacchi M, Cerny T. The cognitive-spiritual dimension--an important addition to the assessment of quality of life: validation of a questionnaire (SELT-M) in patients with advanced cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998; 9:1091-6.
01.10.1998The cognitive-spiritual dimension--an important addition to the assessment of quality of life: validation of a questionnaire (SELT-M) in patients with advanced cancer
01.10.1998Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998; 9:1091-6
Van Wegberg B, Castiglione M, Hürny C, Bernhard J, Von Rohr E, Schaad R, Helwig S, Heusser P, Bacchi M, Cerny Thomas